ACRS: Aclaris Therapeutics, Inc. Stock

by  •  • Comments Off on ACRS: Aclaris Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 84.40
Enterprise Value ($M) 44.52
Book Value ($M) 157.18
Book Value / Share 2.22
Price / Book 0.54
NCAV ($M) 88.63
NCAV / Share 1.25
Price / NCAV 0.95

Profitability (mra)
Return on Invested Capital (ROIC) -0.55
Return on Assets (ROA) -0.39
Return on Equity (ROE) -0.50

Liquidity (mrq)
Quick Ratio 4.16
Current Ratio 4.16

Balance Sheet (mrq) ($M)
Current Assets 128.86
Assets 197.41
Liabilities 40.23
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 31.25
Operating Income -117.63
Net Income -88.48
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -78.33
Cash from Investing 46.22
Cash from Financing 26.71

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Rock Springs Capital Management LP 4.23 -24.30
02-14 13G/A Biotechnology Value Fund L P 0.00 -100.00
02-14 13G/A Venrock Healthcare Capital Partners II, L.P. 0.00 -100.00
02-14 13G/A Citadel Advisors Llc 7.60
02-14 13G/A Ra Capital Management, L.p. 0.00 -100.00
02-14 13G Millennium Management Llc 5.30 8.35
02-14 13G/A Tang Capital Partners Lp 2.50 -59.58
02-13 13G/A Foresite Capital Fund IV, L.P. 0.00 -100.00
02-13 13G Vanguard Group Inc 6.67
02-08 13G/A BML Investment Partners, L.P. 13.30 108.80
01-25 13G/A BlackRock Inc. 8.30 16.09
12-11 13G/A Wellington Management Group Llp 0.00 -100.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
2023-11-06 10-Q 7 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-07 10-Q 7 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-08 10-Q 7 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-26 99,250 413,601 24.00
2024-04-25 203,023 321,038 63.24
2024-04-24 359,459 258,892 138.85
2024-04-23 130,577 168,912 77.30
2024-04-22 128,676 131,083 98.16

(click for more detail)

Similar Companies
ABUS – Arbutus Biopharma Corporation ACAD – ACADIA Pharmaceuticals Inc.
ACLX – Arcellx, Inc. ACT – Enact Holdings, Inc.
ADPT – Adaptive Biotechnologies Corporation


Financial data and stock pages provided by
Fintel.io